部位 | ICD-O-3 | 合計 | 男性 | 女性 | |||
---|---|---|---|---|---|---|---|
件数 | % | 件数 | % | 件数 | % | ||
全部位 | 3,016 | 100.0% | 1,657 | 100.0% | 1,359 | 100.0% | |
頭頸部 | C00-C14 C30-C32 | 166 | 5.5% | 119 | 7.2% | 47 | 3.5% |
食道 | C15 | 218 | 7.2% | 189 | 11.4% | 29 | 2.1% |
胃 | C16 | 232 | 7.7% | 173 | 10.4% | 59 | 4.3% |
大腸 | C18-C21 | 218 | 7.2% | 141 | 8.5% | 77 | 5.7% |
( 結腸 ) | C18 | 113 | 3.7% | 68 | 4.1% | 45 | 3.3% |
( 直腸S状結腸移行部、直腸 、肛門及び肛門管 ) | C19-C21 | 105 | 3.5% | 73 | 4.4% | 32 | 2.4% |
膵 | C25 | 134 | 4.4% | 73 | 4.4% | 61 | 4.5% |
気管、気管支及び肺 | C33-C34 | 215 | 7.1% | 138 | 8.3% | 77 | 5.7% |
皮膚(黒色腫以外) | C44 | 107 | 3.5% | 52 | 3.1% | 55 | 4.0% |
乳房 | C50 | 283 | 9.4% | 2 | 0.1% | 281 | 20.7% |
子宮 | C53-C55 | 217 | 7.2% | - | - | 217 | 16.0% |
( 子宮頚 ) | C53 | 125 | 4.1% | - | - | 125 | 9.2% |
( 子宮体部 ) | C54 | 92 | 3.1% | - | - | 92 | 6.8% |
( 子宮NOS ) | C55 | 0 | 0.0% | - | - | 0 | 0.0% |
前立腺 | C61 | 250 | 8.3% | 250 | 15.1% | - | - |
髄膜、脳、脊髄、脳神経及びその他の中枢神経系 | C70-C72 | 117 | 3.9% | 55 | 3.3% | 62 | 4.6% |
悪性リンパ腫 | M959-M972 | 141 | 4.7% | 84 | 5.1% | 57 | 4.2% |
その他(100件未満) | 718 | 23.8% | 381 | 23.0% | 337 | 24.8% |
※4 登録症例が年間100例に満たないものはその他に含みます。
Ⅰ期 | Ⅱ期 | Ⅲ期 | Ⅳ期 | 不明 | 空欄 | 合計 | |
---|---|---|---|---|---|---|---|
手術または内視鏡的治療の割合 | 98.0% | 100.0% | 100.0% | 12.5% | 50.0% | 0.0% | 86.6% |
手術 | 32.0% | 100.0% | 100.0% | 12.5% | 0.0% | 0.0% | 32.8% |
(うち、体腔鏡的治療) | 20.0% | 20.0% | 0.0% | 0.0% | 0.0% | 0.0% | 16.7% |
内視鏡的治療 | 69.3% | 0.0% | 0.0% | 0.0% | 50.0% | 0.0% | 56.5% |
放射線療法 | 0.0% | 0.0% | 0.0% | 4.2% | 0.0% | 0.0% | 0.5% |
化学療法 | 2.0% | 60.0% | 80.0% | 79.2% | 50.0% | 0.0% | 16.1% |
レーザー等治療 | 0.7% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.5% |
(重複あり)
0期 | Ⅰ期 | Ⅱ期 | Ⅲ期 | Ⅳ期 | 不明 | 空欄 | 合計 | |
---|---|---|---|---|---|---|---|---|
手術または内視鏡的治療の割合 | 100.0% | 100.0% | 100.0% | 100.0% | 77.8% | 60.0% | 100.0% | 94.0% |
手術 | 0.0% | 88.9% | 100.0% | 100.0% | 77.8% | 0.0% | 66.7% | 70.0% |
(うち、体腔鏡的治療) | 0.0% | 48.1% | 18.2% | 12.5% | 5.6% | 0.0% | 0.0% | 19.0% |
内視鏡的治療 | 100.0% | 11.1% | 0.0% | 0.0% | 0.0% | 60.0% | 33.3% | 24.0% |
放射線療法 | 0.0% | 0.0% | 0.0% | 0.0% | 5.6% | 0.0% | 0.0% | 1.0% |
化学療法 | 0.0% | 22.2% | 31.8% | 12.5% | 55.6% | 0.0% | 0.0% | 24.0% |
(重複あり)
Ⅰ期 | Ⅱ期 | Ⅲ期 | Ⅳ期 | 不明 | 空欄 | 合計 | |
---|---|---|---|---|---|---|---|
手術または内視鏡的治療の割合 | 43.3% | 53.8% | 61.1% | 0.0% | 0.0% | 100.0% | 50.8% |
手術 | 43.3% | 53.8% | 55.6% | 0.0% | 0.0% | 100.0% | 49.2% |
内視鏡的治療 | 0.0% | 0.0% | 5.6% | 0.0% | 0.0% | 0.0% | 1.6% |
放射線療法 | 3.3% | 0.0% | 11.1% | 0.0% | 0.0% | 0.0% | 4.8% |
化学療法 | 40.0% | 23.1% | 38.9% | 0.0% | 100.0% | 0.0% | 36.5% |
TAE | 43.3% | 30.8% | 11.1% | 0.0% | 0.0% | 0.0% | 30.2% |
レーザー等治療 | 26.7% | 15.4% | 0.0% | 0.0% | 0.0% | 0.0% | 15.9% |
(重複あり)
Ⅰ期 | Ⅱ期 | Ⅲ期 | Ⅳ期 | 不明 | 空欄 | 合計 | |
---|---|---|---|---|---|---|---|
手術または内視鏡的治療の割合 | 75.3% | 80.0% | 18.2% | 5.3% | 33.3% | 100.0% | 47.0% |
手術 | 76.6% | 80.0% | 18.2% | 5.3% | 33.3% | 100.0% | 47.6% |
(うち、体腔鏡的治療) | 64.9% | 60.0% | 12.1% | 2.6% | 33.3% | 50.0% | 38.6% |
放射線療法 | 24.7% | 10.0% | 39.4% | 39.5% | 16.7% | 0.0% | 29.5% |
化学療法 | 10.4% | 40.0% | 69.7% | 76.3% | 33.3% | 0.0% | 39.8% |
レーザー等治療 | 1.3% | 0.0% | 0.0% | 0.0% | 16.7% | 0.0% | 1.2% |
その他 | 0.0% | 0.0% | 3.0% | 0.0% | 0.0% | 0.0% | 0.6% |
(重複あり)
0期 | Ⅰ期 | Ⅱ期 | Ⅲ期 | Ⅳ期 | 不明 | 空欄 | 合計 | |
---|---|---|---|---|---|---|---|---|
手術の割合 | 96.7% | 97.7% | 89.3% | 87.5% | 22.2% | 50.0% | 0.0% | 88.4% |
放射線療法 | 56.7% | 50.0% | 42.9% | 62.5% | 33.3% | 100.0% | 0.0% | 50.4% |
化学療法 | 6.7% | 18.2% | 67.9% | 62.5% | 100.0% | 0.0% | 0.0% | 35.5% |
内分泌療法 | 50.0% | 81.8% | 64.3% | 75.0% | 33.3% | 0.0% | 0.0% | 64.5% |
(重複あり)